Literature DB >> 16794151

Association of stellate mammographic pattern with survival in small invasive breast tumors.

M Camille Alexander1, Bonnie C Yankaskas, Karl W Biesemier.   

Abstract

OBJECTIVE: We tested whether the stellate mammographic pattern of presentation of small breast tumors is a better indicator of survival than other patterns.
MATERIALS AND METHODS: Patients with primary invasive breast cancer diagnosed in 1993-1997 were grouped according to the size of the lesion: 0.1-0.9 cm and 1.0-1.4 cm. Each tumor was placed in one of five mammographic prognostic categories: stellate without calcifications; circular without calcifications; and calcifications with or without tumor mass in a casting, crushed-stone, or other (powdery, punctuate, or round) pattern. To assess reproducibility, a second radiologist gave an independent interpretation in the first 109 cases. Descriptive data were stratified by tumor size, and tests of association were done with an extension of Fisher's exact test. Odds ratios and confidence intervals were computed. Weighted log-rank test and Kaplan-Meier survival curves were used to compare breast cancer survival in the stellate group compared with the other groups.
RESULTS: Two hundred one consecutive patients with a median follow-up period of 7.4 years were identified. There were nine breast cancer deaths. The stellate morphologic pattern was most common (91 [45.3%] of 201 cases), yet there was only one breast cancer death in this group (survival rate, 98.9%; 95% confidence interval [CI], 96.7-100%). In the group of stellate lesions smaller than 1.0 cm, 67.6% (25/37) of the tumors were well-differentiated without lymph node metastasis (30 [96.8%] of 31 cases), and there were no deaths. In the group of stellate lesions measuring 1.0-1.4 cm, 66.7% (36/54) of the tumors were well-differentiated with a 19.6% risk of lymph node metastasis, one death, and a survival rate of 98.1% (52/53; 95% CI, 94.4-100%). Circular tumors accounted for 29.9% (60/201) of tumors and 55.6% (5/9) of breast cancer deaths. Casting and crushed-stone microcalcifications were associated with 33.3% (3/9) of disease-specific deaths. A weighted kappa value of 0.89 (CI, 0.83-0.94) indicated very high agreement of pattern assignment.
CONCLUSION: Stellate tumors had a significantly better survival prognosis than tumors with other patterns even though there were no differences in treatment. By recognizing these small malignant lesions, trained radiologists may be able to identify tumors that pose negligible risk of breast cancer death.

Entities:  

Mesh:

Year:  2006        PMID: 16794151     DOI: 10.2214/AJR.04.0582

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  An investigation into the mammographic appearances of missed breast cancers when recall rates are reduced.

Authors:  Norhashimah Mohd Norsuddin; Claudia Mello-Thoms; Warren Reed; Mary Rickard; Sarah Lewis
Journal:  Br J Radiol       Date:  2017-06-16       Impact factor: 3.039

2.  Tumor characteristics in screen-detected and symptomatic breast cancers.

Authors:  István Pálka; Gyöngyi Kelemen; Katalin Ormándi; György Lázár; Tibor Nyári; László Thurzó; Zsuzsanna Kahán
Journal:  Pathol Oncol Res       Date:  2008-03-06       Impact factor: 3.201

3.  Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.

Authors:  Ying Chen; Tor A Klingen; Elisabeth Wik; Hans Aas; Einar Vigeland; Knut Liestøl; Øystein Garred; Jan Mæhlen; Lars A Akslen; Jon Lømo
Journal:  Diagn Pathol       Date:  2014-12-19       Impact factor: 2.644

4.  Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?

Authors:  Song Liu; Xiao-Dong Wu; Wen-Jian Xu; Qing Lin; Xue-Jun Liu; Ying Li
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

5.  Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype.

Authors:  Li Sturesdotter; Malte Sandsveden; Kristin Johnson; Anna-Maria Larsson; Sophia Zackrisson; Hanna Sartor
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

6.  Imaging Predictors for Nonsentinel Lymph Node Metastases in Breast Cancer Patients.

Authors:  Yizi Cong; Suxia Wang; Haidong Zou; Shiguang Zhu; Xingmiao Wang; Jianqiao Cao; Ji Wang; Yanqing Liu; Guangdong Qiao
Journal:  Breast Care (Basel)       Date:  2019-10-29       Impact factor: 2.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.